SIRT4 and hepatocellular carcinoma: Wang YS et al. discovered that SIRT4 could inhibit tumorigenesis and advance in HCC through crippling glutamine metabolism and blocking mTOR signaling pathway which based on enhancing the ADP/AMP levels through phosphorylation of AMPK via LKB1 31.